-+ 0.00%
-+ 0.00%
-+ 0.00%

EVOMMUNE - TO USE PROCEEDS TO ADVANCE CLINICAL PROGRAMS INCLUDING EVO570

Reuters·11/04/2026 22:10:00

Please log in to view news